Corrigendum to ``Co-encapsulation of doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors'' [Translational Oncology 7 (2014), 525–536]

• Manu M. Joseph,
• S.R. Aravind,
• Suraj K. George,
• Raveendran K. Pillai,
• S. Mini,
• T.T. Sreelekha

Affiliations

Manu M. Joseph

Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre, Trivandrum, Kerala, India

S.R. Aravind

Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre, Trivandrum, Kerala, India

Suraj K. George

Department of Hematopathology, UT MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA

Raveendran K. Pillai

Department of Pathology, Regional Cancer Centre, Trivandrum, Kerala, India

S. Mini

Department of Biochemistry, University of Kerala, Trivandrum, Kerala, India

T.T. Sreelekha

Laboratory of Biopharmaceuticals and Nanomedicine, Division of Cancer Research, Regional Cancer Centre, Trivandrum, Kerala, India; Corresponding author. T.T. Sreelekha Ph.D., Asst. Professor, Division of Cancer Research, Regional Cancer Centre (RCC), Trivandrum-695011, Kerala, India.